Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

134.75
+7.535.92%
Post-market: 133.41-1.3400-0.99%19:58 EDT
Volume:1.81M
Turnover:239.00M
Market Cap:8.87B
PE:-60.45
High:136.86
Open:126.04
Low:121.92
Close:127.22
52wk High:155.44
52wk Low:23.30
Shares:65.83M
Float Shares:64.65M
Volume Ratio:1.30
T/O Rate:2.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2293
EPS(LYR):-1.2987
ROE:-29.59%
ROA:-13.09%
PB:19.90
PE(LYR):-103.76

Loading ...

Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock

THOMSON REUTERS
·
Aug 05

Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 04

Twist Bioscience Corp : Leerink Partners Raises Target Price $120.00 from $110.00

THOMSON REUTERS
·
Aug 04

Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), Twist Bioscience (TWST)

TIPRANKS
·
Aug 04

Stock Track | Twist Bioscience Soars 5.16% Intraday After Q3 Revenue Beat, Raised FY Guidance, and EBITDA Breakeven Outlook

Stock Track
·
Aug 03

Twist Bioscience Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 03

Movement Alert|Twist Bioscience Corp Falls 9.51% in Regular Trading, Fiscal Q3 Swings to Loss Exceeding Expectations

Market Focus
·
Aug 03

Movement Alert|Twist Bioscience Corp Falls 6.22% in Pre-Market Trading, Fiscal Q3 Loss Wider Than Expected Despite Revenue Beat

Market Focus
·
Aug 03

Stock Track | Twist Bioscience Plunges 6.22% in Pre-market as Fiscal Q3 Loss Wider Than Expected

Stock Track
·
Aug 03

S&P 500 Futures up in Premarket Trading; GameStop, Twist Bioscience Lag

Dow Jones
·
Aug 03

GUIDANCE: (TWST) Twist Bioscience Expects Fiscal 2026 Revenue Range $456M - $457M, vs. FactSet Est of $446.4M

MT Newswires Live
·
Aug 03

Twist Bioscience Q3 EPS $(0.56) Misses $(0.50) Estimate, Sales $118.376M Beat $114.490M Estimate

Benzinga Earnings
·
Aug 03

Earnings Flash (TWST) Twist Bioscience Posts Fiscal Q3 Loss $0.56 a Share, vs. FactSet Est of $0.51 Loss

MT Newswires Live
·
Aug 03

Twist Bioscience FY26 Q3 Adjusted Ebitda Loss Narrows to $(11.3) Million; Revenue Rises 23% YoY to $118.4 Million

Reuters
·
Aug 03

Twist Bioscience Q3 EPS USD -0.56

THOMSON REUTERS
·
Aug 03

Twist Bioscience Outlook Q4 to Achieve Adjusted Ebitda Breakeven

THOMSON REUTERS
·
Aug 03

Twist Bioscience Outlook FY Gross Margin to be Above 52%

THOMSON REUTERS
·
Aug 03

Twist Bioscience Posts Fiscal Q3 2026 Earnings Report and Investor Presentation Online

Reuters
·
Aug 03

Twist Bioscience Corp: for the Fourth Quarter, Twist Expects Total Revenue of Approximately $123 Million to $124 Million

THOMSON REUTERS
·
Aug 03

Twist Bioscience Corp: Q3 Net Loss $0.56 Per Diluted Share

THOMSON REUTERS
·
Aug 03